Action PFZ PFIZER
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Communiqués PFIZER Euronext Paris

Actions

PFZ

US7170811035

Cours en clôture Euronext Paris
Autres places de cotation
- - Graphique intraday de PFIZER
25/06 CVRx, Inc. annonce la nomination de Robert Allen John au poste de Chief Revenue Officer, à compter du 27 juin 2024 CI
24/06 La Cour suprême des États-Unis donne aux entreprises pharmaceutiques une chance de contrecarrer les poursuites pour financement du terrorisme RE

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Divisional Applications – The Story Continues?
AQ
Divisional Applications In Russia: Does The Story Continue?
AQ
Pfizer Invites Public to View and Listen to Webcast of July 30 Conference Call with Analysts
BU
Pfizer Inc. - ELREXFIO Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory Multiple Myeloma
AQ
ELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory Multiple Myeloma
BU
Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with Duchenne Muscular Dystrophy
BU
Pfizer : Global Asian Alliance Colleague Resource Group Celebrates Asian American Native Hawaiian Pacific Islander (AANHPI) Heritage Month
PU
Pfizer : Goldman Sachs 45th Annual Global Healthcare Conference Transcript
PU
Pfizer : 2024 Pride Journal—Together in Pride
PU
Pfizer : Goldman Sachs 45th Annual Global Healthcare Conference Event Announcement
PU
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
AQ
Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608
AQ
Pfizer : May Social Media Round-Up—Clinicals Trials Day, the TIME 100, and the Future of Cancer Care
PU
Delhi HC's Ruling In Pfizer vs. Renovision; An Analysis
AQ
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
BU
Pfizer’s ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/​Refractory Diffuse Large B-cell Lymphoma (DLBCL)
BU
Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma
BU
Patents, Policies And Privacy: The Highs And Lows Of Technology In IP
AQ
Pfizer’s LORBRENA® CROWN Study Shows Majority of Patients with ALK-Positive Advanced Lung Cancer Living Beyond Five Years Without Disease Progression
BU
Pfizer : Receives Positive CHMP Opinion for its One-Time Gene Therapy for Adults with Hemophilia B
PU
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action PFE
  4. Action PFZ
  5. Actualités PFIZER
  6. Communiqués